Hwyda Arafat, M.D., Ph.D., Thomas Jefferson University (IMAGE)

Thomas Jefferson University

Hwyda Arafat, M.D., Ph.D., Thomas Jefferson University

Caption

Thomas Jefferson University research suggests a potential target -- Angiotensin II type 2 receptor -- for chemopreventive agents to fight pancreatic cancer.

Credit

TJUH

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.